Contact
Please use this form to send email to PR contact of this press release:
Frontier Medicines to Spotlight Lead Candidate, Novel Dual KRASG12C Inhibitor FMC-376, and the Frontierâ„¢ Platform at the 2023 AACR Annual Meeting
TO: